Cingulate (CINGW) Competitors $0.06 +0.00 (+6.65%) As of 07/8/2025 02:29 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock CINGW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, AMPE, ACABW, BFRIW, BTMDW, and BCTXWShould you be buying Cingulate stock or one of its competitors? The main competitors of Cingulate include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Ampio Pharmaceuticals (AMPE), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), and BriaCell Therapeutics (BCTXW). These companies are all part of the "pharmaceutical products" industry. Cingulate vs. Its Competitors 180 Life Sciences 4D pharma Aesther Healthcare Acquisition Ainos Alvotech Ampio Pharmaceuticals Atlantic Coastal Acquisition Corp. II Biofrontera biote BriaCell Therapeutics 180 Life Sciences (NASDAQ:ATNFW) and Cingulate (NASDAQ:CINGW) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, earnings, risk, profitability, media sentiment, valuation and dividends. Which has preferable valuation & earnings, ATNFW or CINGW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio180 Life SciencesN/AN/AN/AN/AN/ACingulateN/AN/AN/AN/AN/A Is ATNFW or CINGW more profitable? Company Net Margins Return on Equity Return on Assets 180 Life SciencesN/A N/A N/A Cingulate N/A N/A N/A Does the media favor ATNFW or CINGW? In the previous week, 180 Life Sciences' average media sentiment score of 0.00 equaled Cingulate'saverage media sentiment score. Company Overall Sentiment 180 Life Sciences Neutral Cingulate Neutral Summary180 Life Sciences and Cingulate tied by winning 0 of the 0 factors compared between the two stocks. Get Cingulate News Delivered to You Automatically Sign up to receive the latest news and ratings for CINGW and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CINGW vs. The Competition Export to ExcelMetricCingulateBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$129.35M$5.51B$8.96BDividend YieldN/A3.74%5.25%4.02%P/E RatioN/A3.4228.0520.15Price / SalesN/A4,200.57438.14127.85Price / CashN/A13.1937.0657.97Price / BookN/A41.988.125.62Net IncomeN/A-$92.79M$3.16B$248.50M7 Day PerformanceN/A8.72%4.40%5.54%1 Month PerformanceN/A2.11%4.09%7.52%1 Year PerformanceN/A177.42%34.53%22.06% Cingulate Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CINGWCingulateN/A$0.06+6.7%N/A+690.7%$0.00N/A0.0020Positive NewsGap UpATNFW180 Life SciencesN/A$0.01-13.4%N/A-21.0%$0.00N/A0.007Positive NewsGap UpLBPSW4D pharmaN/AN/AN/AN/A$0.00$522K0.00N/AAEHAWAesther Healthcare AcquisitionN/A$0.01flatN/A-95.6%$0.00N/A0.002AIMDWAinosN/A$0.12-7.7%N/A+74.2%$0.00$106.21K0.0040Gap DownALVOWAlvotechN/A$1.73+1.8%N/A-35.2%$0.00$585.60M0.004Positive NewsAMPEAmpio Pharmaceuticals0.1474 of 5 stars$0.00-96.3%N/A-97.3%$0.00N/A0.0020Gap DownACABWAtlantic Coastal Acquisition Corp. IIN/A$0.02flatN/A-66.2%$0.00N/A0.0015BFRIWBiofronteraN/A$0.11+16.9%N/A+157.7%$0.00$38.00M0.0070Gap UpBTMDWbioteN/A$0.01-2.0%N/AN/A$0.00$199.38M0.00N/ABCTXWBriaCell TherapeuticsN/A$0.06-17.1%N/A-69.0%$0.00N/A0.008News CoverageGap Down Related Companies and Tools Related Companies ATNFW Competitors LBPSW Competitors AEHAW Competitors AIMDW Competitors ALVOW Competitors AMPE Competitors ACABW Competitors BFRIW Competitors BTMDW Competitors BCTXW Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CINGW) was last updated on 7/9/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cingulate Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cingulate With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CINGW Stock Alerts